Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 24/02/28

Trade details

Type
Insider sale
Amount
$127,244.56
Shares · price
7,624 sh · $16.69 a share
Held after
4,376 sh
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Trade date
24/02/26
Filed
24/02/28
Days to filing
2 days

Sold 63.5% of holdings

Share of holding sold
63.5%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/27~24/03/27

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19

Samuel Kintz, CEO — sold $127.2K of Enliven Therapeutics ELVN · 63.5% of holdings · 10b5-1 plan | Whalegun